Infinity Deep Brain Stimulation (DBS) system is FDA approved for patients suffering from Parkinson's disease or essential tremor.- St Jude Medical.

St. Jude Medical, Inc. announced the FDA approval and first implant of the St. Jude Medical Infinity Deep Brain Stimulation (DBS) system and its DBS directional leads, the first directional lead approved in the United States. Combined with the first and only wireless iOS software platform available to DBS patients and physicians, the St. Jude Medical Infinity system provides a discreet, personalized experience for patients suffering from Parkinson's disease or essential tremor, while delivering targeted relief of only the necessary areas.

The St. Jude Medical Infinity DBS system was designed to transform the standard of care for movement disorder patients by incorporating a number of patient-centric features. Because the Infinity system is upgradeable, St. Jude Medical offers patients the ability to retain access to the latest technology and therapy options and new modes of stimulation as they are approved via software upgrades, avoiding the need to undergo repeat surgery. St. Jude Medical has also developed technology to allow patients with existing DBS systems from any manufacturer to replace their existing system to take advantage of the advancements enabled by the Infinity system. In addition, patients will now be provided an Apple iPod Touch digital device that allows them to easily manage their therapy. Physicians will program their patient's devices through an iPad Mini digital device. The St. Jude Medical patient and physician programmers use Bluetooth wireless technology, providing a secure, safe, and wireless experience.

The Infinity Deep Brain Stimulation (DBS) system received CE Mark in September 2015.